Press Releases
Pfizer Announces Results From Two Phase 3 TRUMENBA Studies At The European Society For Paediatric Infectious Diseases Meeting
Pfizer Inc announced results of two Phase 3 studies demonstrating the immunogenicity of TRUMENBA® (Meningococcal Group B Vaccine) against invasive meningococcal B (MnB) strains representative...
Press Releases
EU approves Alprolix (rFIXFc) for the Treatment of Haemophilia B
First Fc Fusion Therapy Approved for haemophilia B in the EU to Provide Extended Protection Against Bleeds Swedish Orphan Biovitrum AB and...
Press Releases
Mylan Launches Generic Frova Tablets for for migraine headaches in adults.
Mylan N.V. announced the U.S. launch of Frovatriptan Succinate Tablets 2.5 mg, a generic version of Endo's Frova® Tablets. Mylan received final approval from the...
Press Releases
AbbVie Inc to participate at the UBS Global Health Care Conference
AbbVie will participate in the UBS Global Healthcare Conference on Monday, May 23, 2016. Bill Chase, executive vice president and chief financial officer, will participate...
Press Releases
Empliciti (elotuzumab) for the Treatment of Multiple myeloma treatment from Bristol-Myers Squibb and AbbVie scores EU approval
First and only immunostimulatory antibody approved in the European Union for multiple myeloma Accelerated assessment and approval based on long-term data from ELOQUENT-2,...
Press Releases
EC approves Immuno-Oncology Combination, Bristol-Myers Squibbs Opdivo (nivolumab) + Yervoy (ipilimumab) Regimen, for Treatment of Advanced Melanoma
Opdivo + Yervoy Regimen now approved for unresectable or metastatic melanoma patients, regardless of BRAF mutational status Approval of the Regimen marks a...
Press Releases
Johnson & Johnson opens first international JLABs site in Canada
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.